- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-9098
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies ; volume:34 ; number:1 ; day:26 ; month:3 ; year:2022 ; pages:1-13 ; date:12.2022
The Egyptian Journal of Internal Medicine ; 34, Heft 1 (26.3.2022), 1-13, 12.2022
- Urheber
-
Wambani, Josephine
Okoth, Patrick
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43162-022-00121-z
- URN
-
urn:nbn:de:101:1-2022061810033486370201
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wambani, Josephine
- Okoth, Patrick
- SpringerLink (Online service)
Ähnliche Objekte (12)
Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants